Global Stasis Dermatitis Market - Industry Trends and Forecast to 2028

Market Analysis and Insights: Global Stasis Dermatitis Market

Stasis dermatitis market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.90% in the above-mentioned research forecast period. Increasing prevalence of chronic vein insufficiency, deep vein thrombosis, and a wide range of drugs.

Moreover, increasing research activities and increasing health care expenditure also boost up the market growth. Moreover, rising government initiatives for providing better healthcare and increasing disease awareness act as an opportunity for market growth. But, side effects associated with treatment options, patent expiry and long drug approval process may hamper the global stasis dermatitis market.

Stasis dermatitis is a long-term dermatological disorder caused due to the poor blood circulation in the legs, resulting in chronic venous insufficiency. Stasis dermatitis is also known as gravitational dermatitis, venous stasis dermatitis, venous eczema, or varicose eczema. The major symptom associated with it includes inflammation, ulcers, itchy skin on the lower legs. People suffering from chronic venous insufficiency, varicose veins, deep vein thrombosis, and congestive failure are at higher risk of developing stasis dermatitis. Stasis dermatitis has been reported to affect the older population of 50 years or more than that and most common among the women population. Corticosteroids or topical calcineurin inhibitors are prescribed for the treatment of swelling associated with stasis dermatitis. Antihistamines are indicated for relieving the associated itching. Moreover, antibiotics are used to get relief from infected ulcers.

The prevalence of stasis dermatitis is increasing across the world and has been reported to affect the geriatric population. As the old aged people are increasing throughout the world, the prevalence of stasis dermatitis is also expected to increase and expected to provide the market with the lucrative growth.

This stasis dermatitis market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Stasis Dermatitis Market Scope and Market Size

Stasis dermatitis market is segmented on the basis of treatment, route of administration, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of treatment, the stasis dermatitis market is segmented into corticosteroids, antihistamines, antibiotics and others.
• On the basis of route of administration, the stasis dermatitis market is segmented into oral, parenteral, topical and others.
• On the basis of end-users, the stasis dermatitis market is segmented into clinics, hospitals, dermatology centers and others.
• On the basis of distribution channel, the stasis dermatitis market is segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.

Stasis Dermatitis Market Country Level Analysis

Stasis dermatitis market is analysed and market size information is provided by country, treatment, route of administration, end-users and distribution channel as referenced above.

The countries covered in the stasis dermatitis market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts for the largest market share due to the increasing geriatric population suffering from dermatological disorders, as approximately 15-20 million people in the U.S. suffering from stasis dermatitis and increasing research and development activities. Europe is also expected to grow exponentially due to the increasing distributional channel of market players for product distribution and rising diagnostic rates. Asia-Pacific is expected to account for the largest market share owing to rising government initiatives for providing better healthcare and increasing investment for boosting up the pharmaceutical industry.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Stasis dermatitis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Stasis dermatitis Market Share Analysis

Stasis dermatitis market competitive landscape provides details by competitor. details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to stasis dermatitis market.

The major players covered in the stasis dermatitis market are Actiza Pharmaceutical Private Limited, Teva Pharmaceuticals USA, Inc., Glenmark Pharmaceutical Inc., Perrigo Company plc, Pfizer Inc., Astellas Pharma US, Inc., Sandoz International GmbH, Veloxis Pharmaceuticals, Inc., GIST LIFE PHARMACEUTICALS, LEXICARE PHARMA PVT. LTD., Bayer AG, Johnson & Johnson Services, Inc., Lannett, Viatris Inc., Sun Pharmaceutical Industries Ltd, Apotex Inc., Hikma Pharmaceuticals PLC, LUPIN, GlaxoSmithKline plc, Zydus Pharmaceuticals, Inc. among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-61423